Showing 19,961 - 19,980 results of 101,820 for search '(( 2 step decrease ) OR ( 5 ((fold decrease) OR (((nn decrease) OR (a decrease)))) ))', query time: 1.39s Refine Results
  1. 19961

    Time course of central retinal thickness (CRT) in all eyes. by Yasuyuki Sotani (20114144)

    Published 2025
    “…<p>Mean CRT (μm ± standard deviation) significantly decreased from 504.7 ± 118.2 μm preoperatively to 302.5 ± 60.5 at 1 month, 307.5 ± 64.4 at 3 months, 286.8 ± 49.0 at 6 months, 305.3 ± 79.5 at 12 months, 288.8 ± 79.1 at 24 months, and 295.2 ± 87.4 at 36 months (Kruskal–Wallis test, P < 0.001; Dunn’s test, **P < 0.01). …”
  2. 19962

    Table 1_Trends and forecasts of vitamin A deficiency burden in China, 1990–2035.docx by Zhongming Ye (21865547)

    Published 2025
    “…Significant age and sex disparities exist. Children under 5 years bear the heaviest burden. Women have a higher incidence and prevalence than men, while DALY rates are lower in men across all age groups. …”
  3. 19963

    Zinc exposure attenuates NR2A clusters and currents. by Jia Zhu (135506)

    Published 2012
    “…(B) and (C) show the quantification data of (A). Both the number and mean intensity of NR2A clusters significantly decreased after zinc treatment. …”
  4. 19964
  5. 19965
  6. 19966

    CsrA modulates the expression of a thiamine pyrophosphate (TPP) riboswitch element. by Tobias Sahr (3756775)

    Published 2017
    “…<b>B</b>) EMSA with 200nM of biotinylated thi-element (TPP) RNA and purified CsrA: Lane 1: no CsrA, lane 2: 1.0 μM CsrA, lane 3: 2.0 μM CsrA, lane 4: 5.0 μM CsrA, lane 5: 5.0 μM CsrA + 2.0 μM unlabeled RsmZ. …”
  7. 19967

    Table_3_Immunogenicity, Effectiveness, and Safety of Inactivated Virus (CoronaVac) Vaccine in a Two-Dose Primary Protocol and BNT162b2 Heterologous Booster in Brazil (Immunita-001)... by Rafaella F. Q. Grenfell (12841457)

    Published 2022
    “…Cellular immune response measurement pointed out a mixed immune profile with a robust release of chemokines, cytokines, and growth factors on the first month after CoronaVac vaccination followed by a gradual reduction over time and no increase after the booster dose. …”
  8. 19968

    Table_2_Immunogenicity, Effectiveness, and Safety of Inactivated Virus (CoronaVac) Vaccine in a Two-Dose Primary Protocol and BNT162b2 Heterologous Booster in Brazil (Immunita-001)... by Rafaella F. Q. Grenfell (12841457)

    Published 2022
    “…Cellular immune response measurement pointed out a mixed immune profile with a robust release of chemokines, cytokines, and growth factors on the first month after CoronaVac vaccination followed by a gradual reduction over time and no increase after the booster dose. …”
  9. 19969

    Table_4_Immunogenicity, Effectiveness, and Safety of Inactivated Virus (CoronaVac) Vaccine in a Two-Dose Primary Protocol and BNT162b2 Heterologous Booster in Brazil (Immunita-001)... by Rafaella F. Q. Grenfell (12841457)

    Published 2022
    “…Cellular immune response measurement pointed out a mixed immune profile with a robust release of chemokines, cytokines, and growth factors on the first month after CoronaVac vaccination followed by a gradual reduction over time and no increase after the booster dose. …”
  10. 19970

    Table_1_Immunogenicity, Effectiveness, and Safety of Inactivated Virus (CoronaVac) Vaccine in a Two-Dose Primary Protocol and BNT162b2 Heterologous Booster in Brazil (Immunita-001)... by Rafaella F. Q. Grenfell (12841457)

    Published 2022
    “…Cellular immune response measurement pointed out a mixed immune profile with a robust release of chemokines, cytokines, and growth factors on the first month after CoronaVac vaccination followed by a gradual reduction over time and no increase after the booster dose. …”
  11. 19971

    The effectiveness and safety of various treatments for hemophilia in China: a literature review and evidence mapping by Yu Yang (83671)

    Published 2025
    “…This study revealed a decrease in both annualized bleeding rate (ABR) and annualized joint bleeding rate (AJBR) following prophylaxis treatment and immune tolerance induction (ITI) treatment. …”
  12. 19972

    Table 1_Epidemiology and genetic characteristics of coxsackievirus A16 associated with hand-foot-mouth disease in Hangzhou city, Zhejiang province from 2021 to 2024.docx by Qihao Xu (5513795)

    Published 2025
    “…The detected number of CV-A16 began to rise in March, peaked in May–August, and then decreased in September. …”
  13. 19973

    Retinol and mineral status in grazing foals during the dry season by Maria Lindomárcia Leonardo da Costa (12802135)

    Published 2022
    “…Beta-carotene in grass showed a downward trend over time from 38.53 to 0.09 mg/kg of dry matter. …”
  14. 19974

    Image 1_Epidemiology and genetic characteristics of coxsackievirus A16 associated with hand-foot-mouth disease in Hangzhou city, Zhejiang province from 2021 to 2024.jpeg by Qihao Xu (5513795)

    Published 2025
    “…The detected number of CV-A16 began to rise in March, peaked in May–August, and then decreased in September. …”
  15. 19975
  16. 19976
  17. 19977
  18. 19978

    MiR-24 target Trib3 regulates hematopoietic gene expression networks. by Jeffrey L. Kurkewich (3044211)

    Published 2017
    “…EBF1 and Pax5 were significantly downregulated in ShTrb3 knockdown cells <b>F)</b> Trib3 knockdown in A20 cells resulted in decreased FoxO1 expression by immunoblot analysis. …”
  19. 19979

    hTERT<sup>+</sup>-transfected human lung epithelial A549 cells upregulate FLIP levels and acquire resistance to Fas induced apoptosis. by Nissim Arish (736264)

    Published 2015
    “…(B) Histogram plots of flow cytometry analysis showing decreased Annexin V staining in hTERT<sup>+</sup> (red) when compared to hTERT<sup>ctrl</sup> (black) transfected cells (A549). …”
  20. 19980